NLRP3 inflammasome–driven hemophagocytic lymphohistiocytosis occurs independent of IL-1β and IL-18 and is targetable by BET inhibitors

Journal:
Science Advances
Published:
DOI:
10.1126/sciadv.adv0079
Affiliations:
10
Authors:
15
Go to article
Institutions Authors Share
Walter and Eliza Hall Institute of Medical Research (WEHI), Australia
5.083333
 0.34
The University of Melbourne (UniMelb), Australia
5.083333
 0.34
Dorevitch Pathology, Australia
1.000000
 0.07
Bicycle Therapeutics Limited, United Kingdom (UK)
1.000000
 0.07
Curve Therapeutics, United Kingdom (UK)
1.000000
 0.07
Hudson Institute of Medical Research, Australia
0.500000
 0.03
Monash University, Australia
0.500000
 0.03
National University of Singapore (NUS), Singapore
0.333333
 0.02
Olivia Newton-John Cancer Wellness and Research Centre, Australia
0.250000
 0.02
La Trobe School of Cancer Medicine, Australia
0.250000
 0.02
Interested in Cardiovascular Medicine and Haematology?